- Home
- PTCT vs TENB Comparison
PTCT vs TENB Comparison
Compare PTCT & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- TENB
- Stock Information
- Founded
- PTCT 1998
- TENB 2002
- Country
- PTCT United States
- TENB United States
- Employees
- PTCT N/A
- TENB N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- TENB Computer Software: Prepackaged Software
- Sector
- PTCT Health Care
- TENB Technology
- Exchange
- PTCT Nasdaq
- TENB Nasdaq
- Market Cap
- PTCT 4.1B
- TENB 3.6B
- IPO Year
- PTCT 2013
- TENB 2018
- Fundamental
- Price
- PTCT $60.65
- TENB $29.81
- Analyst Decision
- PTCT Buy
- TENB Buy
- Analyst Count
- PTCT 14
- TENB 17
- Target Price
- PTCT $67.00
- TENB $41.06
- AVG Volume (30 Days)
- PTCT 1.2M
- TENB 1.3M
- Earning Date
- PTCT 11-06-2025
- TENB 10-29-2025
- Dividend Yield
- PTCT N/A
- TENB N/A
- EPS Growth
- PTCT N/A
- TENB N/A
- EPS
- PTCT 7.72
- TENB N/A
- Revenue
- PTCT $1,764,929,000.00
- TENB $949,251,000.00
- Revenue This Year
- PTCT $119.89
- TENB $11.66
- Revenue Next Year
- PTCT N/A
- TENB $7.86
- P/E Ratio
- PTCT $7.88
- TENB N/A
- Revenue Growth
- PTCT 96.00
- TENB 11.41
- 52 Week Low
- PTCT $33.88
- TENB $28.51
- 52 Week High
- PTCT $62.18
- TENB $45.45
- Technical
- Relative Strength Index (RSI)
- PTCT 69.46
- TENB 44.55
- Support Level
- PTCT $58.87
- TENB $29.77
- Resistance Level
- PTCT $62.18
- TENB $31.27
- Average True Range (ATR)
- PTCT 2.13
- TENB 0.75
- MACD
- PTCT 0.52
- TENB -0.05
- Stochastic Oscillator
- PTCT 88.43
- TENB 22.48
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About TENB Tenable Holdings Inc.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.